Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival - Wikidata - wikimedia - TriplyDB

Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival

Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival

http://www.wikidata.org/entity/Q33406769

about

Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.Immunotherapy for ovarian cancer.Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.Overexpressed oncogenic tumor-self antigens Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen.Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?

P2860

Q35129224-9657628A-962A-46A2-AB58-6E7AF069D641 Q35164189-08EEF319-4631-413C-9EF1-6A5012775B56 Q35498335-2D2948DC-D3BB-45F2-9D88-31405DFCFFDF Q35886756-24CE9883-DF54-473F-BAA4-7D930856786C Q36596837-3D860012-3F5B-4898-A083-20F436B5C727 Q37195269-A891FBA9-442F-4A58-9A34-DA8401F404E2 Q38209599-41FEA694-40F9-4415-B5D5-A8BE5FB8B04D

P2860

Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival

http://www.wikidata.org/entity/Q33406769

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Overlapping synthetic peptides ...... ne in mice: prolonged survival

@ast

Overlapping synthetic peptides ...... ne in mice: prolonged survival

@en

type

label

Overlapping synthetic peptides ...... ne in mice: prolonged survival

@ast

Overlapping synthetic peptides ...... ne in mice: prolonged survival

@en

prefLabel

Overlapping synthetic peptides ...... ne in mice: prolonged survival

@ast

Overlapping synthetic peptides ...... ne in mice: prolonged survival

@en

P1433

Q33406769-E950B4FB-829C-4FD7-9487-F1FBA6EE672D

P1476

Q33406769-19DB21B0-B9B4-4CE3-A8B6-9354CF7A0F64

P2093

Q33406769-4C7C71F4-8E02-4635-AD57-2E993A760EF2

Q33406769-58DCE149-2AC8-43CA-B261-B5525A5F0E24

Q33406769-66900F38-C52B-4A88-9CBC-FC44BBBB6D98

Q33406769-675CA807-DD33-41E7-A189-2BB3FCDC2B1D

Q33406769-AD60F2BD-4396-4577-9A8E-F50F4D0F42B5

Q33406769-C49E4311-4641-47FB-94BA-CF4FBABE25A9

Q33406769-E66778F8-8170-485F-B3B4-6EF68E8C0D2C

Q33406769-F3264C0F-EA90-4B78-9796-DDF15F2BB74B

P2860

Q33406769-1471F615-46A1-42CE-92EC-05861A1F81C4

Q33406769-163ACD93-D744-4FFC-871C-0DC0FC9F3A8E

Q33406769-1F898AE2-31BC-4A0C-AA4B-988DA684F9C6

Q33406769-215FBBC7-6EFF-4181-B5B6-610CBC707DD5

Q33406769-22E4AFBB-23F4-4242-8D03-C44EC46C1910

Q33406769-313C9F22-53CF-4E80-83A4-8D6D3640B032

Q33406769-3DC7B6CB-18D8-4AE8-9AF8-2980BC23CBF6

Q33406769-3F94B452-D24D-4520-885B-68CC6D026F58

Q33406769-44869EAB-8A7D-4455-A0C2-2CF65FF3FD79

Q33406769-46200E8C-9222-46EB-8829-8998FB8497EC

P304

Q33406769-8CC1F047-24F4-402A-B3BB-8D71A097FCC3

P31

Q33406769-75634660-BE46-4458-92F4-2D1BC435C37F

P356

Q33406769-042D1E45-0153-4956-A0D3-4CF81F52309A

P407

Q33406769-7198722A-FD54-48BA-AEEF-70EA1C5B7675

P433

Q33406769-BE613E13-A90F-46D7-A5D8-B02190368509

P478

Q33406769-5C047581-EF89-48E3-8ADF-960C6B7EA6AE

P577

Q33406769-3473DC25-4AA8-4A78-82A5-50CE45AAEDB5

P5875

Q33406769-BD74A740-4B15-4B7A-90A6-7E5F40EA76D2

P698

Q33406769-240B1952-5ECA-4EA1-8AAF-69F9ABD22482

P932

Q33406769-E153CCB2-BAC1-40F0-870C-44C427D356FE

P356

J.VACCINE.2009.01.089

P1433

P1476

Overlapping synthetic peptides ...... ne in mice: prolonged survival

@en

P2093

Glenn Dranoff

http://www.w3.org/2001/XMLSchema#string

James B Whitney

http://www.w3.org/2001/XMLSchema#string

Karen S Anderson

http://www.w3.org/2001/XMLSchema#string

Ruth M Ruprecht

http://www.w3.org/2001/XMLSchema#string

Saied Mirshahidi

http://www.w3.org/2001/XMLSchema#string

Sandra Lee

http://www.w3.org/2001/XMLSchema#string

Sosthène Essono

http://www.w3.org/2001/XMLSchema#string

Victor G Kramer

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation and characterization of a novel gene expressed in multiple cancers

Identification of homo- and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

A testis-specific and testis developmentally regulated tumor protein D52 (TPD52)-like protein TPD52L3/hD55 interacts with TPD52 family proteins

Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer

Definition of the tumor protein D52 (TPD52) gene family through cloning of D52 homologues in human (hD53) and mouse (mD52)

A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence

Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52

Immunity to melanoma antigens: from self-tolerance to immunotherapy.

Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.

P304

1825-1833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2009.01.089

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23988832

http://www.w3.org/2001/XMLSchema#string

P698

19201387

http://www.w3.org/2001/XMLSchema#string

P932

4477950

http://www.w3.org/2001/XMLSchema#string